97 related articles for article (PubMed ID: 32360423)
1. Malaria prophylaxis approach during COVID-19 pandemic.
Rodriguez-Valero N; Vera I; Torralvo MR; De Alba T; Ferrer E; Camprubi D; Almuedo Riera A; Gallego RS; Muelas M; Pinazo MJ; Muñoz J
Travel Med Infect Dis; 2020; 38():101716. PubMed ID: 32360423
[No Abstract] [Full Text] [Related]
2. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
[TBL] [Abstract][Full Text] [Related]
3. Overlaying COVID-19 mitigation plans on malaria control infrastructures.
Rahi M; Baharia RK; Das P; Chhibber-Goel J; Sharma A
Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):6-8. PubMed ID: 33045049
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis.
Gürsoy C; Tapan ÖO; Dogan E; Togan T; Demirbilek SG
J Coll Physicians Surg Pak; 2020 Oct; 30(10):168-170. PubMed ID: 33291197
[TBL] [Abstract][Full Text] [Related]
5. Malaria and COVID-19: unmasking their ties.
Hussein MIH; Albashir AAD; Elawad OAMA; Homeida A
Malar J; 2020 Dec; 19(1):457. PubMed ID: 33357220
[TBL] [Abstract][Full Text] [Related]
6. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
[TBL] [Abstract][Full Text] [Related]
8. The host targeting effect of chloroquine in malaria.
Coban C
Curr Opin Immunol; 2020 Oct; 66():98-107. PubMed ID: 32823144
[TBL] [Abstract][Full Text] [Related]
9. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
10. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
Fantini J; Di Scala C; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 May; 55(5):105960. PubMed ID: 32251731
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Depression.
Shader RI
Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
[TBL] [Abstract][Full Text] [Related]
12. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
14. Brazil sustains HIV response during the COVID-19 pandemic.
Pereira GFM
Lancet HIV; 2021 Feb; 8(2):e65. PubMed ID: 33539759
[No Abstract] [Full Text] [Related]
15. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
16. The COVID-19 Pandemic and Mayo Clinic Proceedings.
Nath KA
Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
[No Abstract] [Full Text] [Related]
17. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Emergencias; 2022 Aug; 34(4):305-307. PubMed ID: 35833770
[No Abstract] [Full Text] [Related]
18. Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
Macías J; González-Moreno P; Sánchez-García E; Morillo-Verdugo R; Pérez-Venegas JJ; Pinilla A; Macho M; Martínez M; González-Serna A; Corma A; Real LM; Pineda JA
PLoS One; 2021; 16(4):e0249036. PubMed ID: 33831011
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
20. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
